Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 6—June 2007

Isolation and Characterization of Novel Human Parechovirus from Clinical Samples

Kanako Watanabe*†, Masayasu Oie*, Masaya Higuchi*, Makoto Nishikawa†, and Masahiro Fujii*Comments to Author 
Author affiliations: *Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; †Niigata Prefectural Institute of Public Health and Environmental Sciences, Niigata, Japan

Main Article

Table 1

Neutralization activities of anti-HPeV antibodies using Vero cells*

Antiserum Virus
NII561-2000 HPeV-1 HPeV-2 HPeV-3
NII561-2000 160 10 <10 <10
HPeV-1† <10 >1,280 <10 <10
HPeV-2 <10 <10 160 <10
HPeV-3 <10 <10 <10 >1,280

*HPeV, human parechovirus.
†The HPeV strains used were Harris strain for HPeV-1, Williamson strain for HPeV-2, and A308/99 for HPeV-3.

Main Article

Page created: June 16, 2011
Page updated: June 16, 2011
Page reviewed: June 16, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.